Table 2

Univariate linear regression analysis between SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery trial (SYNTAX) and variables

B coefficient95% CIP value
Age (54–70)2.661.16 to 4.170.01
Gender (reference male)1.56−0.56 to 3.690.15
HB (11.5–14.4)−2.92-4.46, to 1.370.002
CR (0.69–1.0)−0.12−1.20 to 0.950.82
HT2.660.55 to 4.780.01
DM4.882.80 to 6.96<0.001
HL1.98−0.29 to 4.260.09
Smoking2.290.17 to 4.410.03
LDL (93–147)−0.35−1.77 to 1.080.84
RFM (28.9–39.5)4.813.45 to 6.17<0.001
BFP (33.7–42.2)1.960.62 to 3.290.004
BMI (26.0–32.8)1.22−0.15 to 2.610.08
  • BFP, body fat percentage; BMI, body mass index; CR, creatinine; DM, diabetes mellitus; HB, haemoglobin; HL, hyperlipidaemia; HT, hypertension; LDL, low-density lipoprotein; RFM, relative fat mass.